Based in China
Production platform
Entire industrial chain
Integrity

News Center

Our company’s enoxaparin sodium active pharmaceutical ingredient has obtained a registration certificate from Russia.

Category:

Release time:2019-07-15 12:00

The registration documents for the heparin sodium active pharmaceutical ingredient of Hubei Enoray Biopharmaceutical Co., Ltd. have officially passed the review by the Russian health authorities, and... 2019 Year 6 The company has obtained a registration certificate issued by the Russian Ministry of Public Health, marking that our enoxaparin sodium active pharmaceutical ingredient has now secured the “key” to entering the Russian market.

Currently, the registration and application process for other active pharmaceutical ingredients of our company, such as sodium heparin and nadroparin calcium, is proceeding smoothly in Russia.